A metabolite of vitamin D believed to be the metabolically active form in the intestine has recently been isolated in pure form from intestine and unequivocally identified in this laboratory as 1,25-dihydroxycholecalciferol (1,25-(OH)2D3)
than 25-(OH)D3 to initiate intestinal calcium transport (4) (5) (6) . The kidney is the site of synthesis of 1,25-(OH)2D3 from 25-(OH)D3 (7) ; this observation was confirmed by Gray et al. (8) . Other experiments have provided strong evidence that 1,25-(0H2)D3 is the metabolically active form of vitamin D in the intestine (9) (10) (11) . It, therefore, seemed possible that the concentration of 1,25-(OH)2D3 in the serum and intestinal mucosa plays an important role in the adaptation of calcium absorption to the concentration of calcium in the diet (12) .
This report demonstrates that dietary calcium concentration has a profound effect on the in vivo production of 1,25-(OH)2D3 and 21,25-(OH)2D3. Furthermore, these alterations in metabolite balance correlate with changes in serum calcium, but not serum phosphate concentration. An independent study has also shown that dietary strontium has an equally marked effect on the production of 1,25-(OH)2D3 and 21,25-(OH)2D3 from 25-(OH)D3 (J. Omdahl and H. F.
DeLuca, manuscript in preparation)
Abbreviations: 1,25-(OH)2D3, 1,25-dihydroxycholecalciferol; 21,-25-(OH)2D3, 21 325 pmoles of tritiated 25-(OH)D3 was administered intrajugularly in 0.05 ml of 95% ethanol with mild ether anethesia. The rats were fasted at this time, but water continued to be available ad libitum. 12 hr later the rats were killed by decapitation and blood serum was collected. The upper 50 cm of small intestine was quickly removed, flushed with ice-cold saline, slit open, and the mucosa was scraped off with a glass slide. The kidneys and livers were removed. The fore-and hind-limbs were stripped of muscle, the long bones were split, and the marrow was discarded. All tissues were stored at -16'C until they were extracted with chloroform and methanol (14) . In early experiments, the tissue from 3 to 4 animals fed the same diet was combined before extraction, while in later experiments the serum calcium concentrations of the rats were analyzed for similarity before pooling of tissues. In other cases, the tissues from each animal were analyzed individually.
Radioactive metabolites were separated on a 2 X 15 cm column containing 10 g of Sephadex LH-20 equilibrated with 35% Skellysolve B (petroleum ether, b.p. 67-680C) in 65% chloroform (15) . The tissue extracts were applied to the column in 1 ml of the same solvent mixture and eluted with a further 190 ml. Recovery of radioactivity from the columns varied from 90 to 105%.
The elution position of 1,25-(OH)2D3 on this column has been established (2, 8) . The less-polar metabolite was identified as 21,25-(OH)2D3 by cochromatography. A sample of the (Table 1) , however, demonstrate a growth effect of the vitamin even at this low concentration in the diet.
In initial experiments with the vitamin D-deficient rats fed diets with 0.02-2.0% Ca, 14-18% of the total radioactivity in the serum was consistently recovered as 1,25-(OH)2D3. However, in the rats given vitamin D, the recovered radioactivity as 1,25-(OH)2D3 was 17% with 0.02% dietary calcium; this figure decreased to 2.5%o with 0.47% dietary calcium and to 0.8% with 2.0% dietary calcium. It was of great interest that another metabolite, 21,25-(OH)2D3, appeared in rats fed the vitamin D-supplemented diets. This less polar metabolite was identified by cochromatography on the liquid-liquid partition column (Fig. 2B) .
In rats given vitamin D, the suppression by dietary calcium of 1,25-(OH)2D3 production correlates with an increase in serum calcium concentration, whereas the suppression of 21 The relationship between 1,25-(OH)2D3 accumulation in serum and the serum calcium concentration appears to involve an abrupt rather than a gradual change. At serum calcium concentrations above 9.0-9.6 mg/100 ml, production of 1,25-(OH)2D3 is suppressed and 21,25-(OH)2D3 is enhanced, whereas below this range of concentrations, the synthesis of 1,25-(OH)2D3 appears to be unaffected by calcium concentration and the synthesis of 21,25-(OH)2D3 is suppressed. Similar correlations of metabolite patterns with the serum calcium concentration were found in the other tissues analyzed (Table 2) .
It also is apparent ( Table 1 ) that when the initial calcium concentration of the serum is low, a distinct rise of from 1 to 2 mg of calcium per 100 ml of serum occurs in response to the 325-pmole dose of 25-(OH)2D3, whereas when the initial serum calcium concentration is normal, no further rise occurs.
Finally, there is no correlation between inorganic P concentrations of serum and production of the metabolites (Table 3) . These results suggest that it is calcium per se, or possibly the hormones that control the serum calcium concentration, that regulates the synthesis of 1,25-(OH)2D3 and 21,25-(OH)2D3. weeks. The rats were given 1 unit of vitamin D, daily for the last 2 weeks. The fractions in the shaded area were pooled for cochromatography, described below in B.
B. Liquid-liquid partition column cochromatography of 1,000 dpm of the metabolite isolated in A (above) together with 600 dpm of pure 21,25-(OH)1D3 isolated by Suda et al. (16) .
The chromatographic system used is that described by the same investigators. In view of the strong evidence that 1,25-(OH)2D3 is the metabolically active form of vitamin D in the intestine (9) (10) (11) , and that its concentration is regulated by the dietary calcium concentration, we suggest that 1,25-(OH)2D3 is the "endogenous factor" of Nicolaysen et al. (22) . The presence of 1,25-(OH)2D3 is obviously vitamin D-dependent and even slight hypocalcemia stimulates its synthesis. Slight hypocalcemia undoubtedly occurs in the young growing animals that were fed a diet low in calcium concentration, and the hypocalcemia probably causes increased 1,25-(OH)2D3 synthesis. Calcification also may remove calcium from the blood, causing slight hypocalcemia. This tendency to slight hypocalcemia and, hence, 1,25-(OH)2D3 production would persist until the bones are fully calcified or until adequate calcium intake could overcome these needs. Thus, 1,25-(OH)2D3 meets the criteria of Nicolaysen et al. (22) for the endogenous factor.
There is a strong possibility that the concentration of other factors, such as parathyroid hormone or calcitonin, which regulate serum calcium concentration, may be the actual regulators of 1,25-(OH)2D3 synthesis. In this regard, the observation of Kimberg et al. (23) that thyroparathyroidectomy does not abolish the adaptation of calcium absorption to dietary calcium concentration may be relevant. However, more direct studies on the interplay of these hormones with 1,25-(OH)2D3 synthesis are in progress.
The 21,25-(OH)2D3 seen in the normocalcemic animals may not be involved directly in the adaptation mechanism. It is notable that this metabolite activates bone mineral mobilization and has slight activity in intestinal calcium transport (16) . That the kidney has the highest concentration of 21,25-(OH)2D3 suggests a renal function for this compound ( Table  2) . For example, it may play a protective role by preventing hypercalcemia by decreasing the tubular reabsorption of calcium, or it may be involved in tubular phosphate reabsorption.
